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INTRODUCTION
Proper spatiotemporal regulation of cell cycle progression is
essential for the successful development of multicellular
organisms. Many evolutionarily conserved cell cycle regulators
have been identified in both vertebrate and invertebrate
systems. Although their functions in cell cycle progression
have been extensively analyzed, relatively little is known about
how the cell cycle is regulated during development, especially
in vivo. Several studies in Drosophila melanogaster provide us
with a glimpse into the developmental regulation of the cell
cycle. The coordination of embryonic cell division in mitotic
domains foreshadows cell fate domains, as revealed by fate
mapping studies (Foe, 1989). The timing of cell division
coincides with the patterning and differentiation of imaginal
discs (reviewed by Edgar and Lehner, 1996). Alterations of the
cell cycle period or the number of cycles can change the
expression patterns of genes that determine neuronal identity
(Cui and Doe, 1995; Weigmann and Lehner, 1995). Thus,
regulation of the cell cycle is closely related to the regulation
of pattern formation and to differentiation during development.
The central nervous system (CNS) of the fruit fly, Drosophila
melanogaster, is an excellent system in which to study genetic
control of the cell cycle in the context of development. The CNS
contains several populations of neuronal precursor cells called
neuroblasts with characteristic profiles of cell cycle progression
during development (Hofbauer and Campos-Ortega, 1990; Ito
and Hotta, 1991; Truman and Bate, 1988; White and Kankel,
1978). The adult CNS is formed by periods of neurogenesis
during embryonic and larval stages. Larval phase neurogenesis
occurs in a stereotyped spatial and temporal pattern as
mitotically quiescent larval neuroblasts reactivate cell cycle
progression (Fig. 1). Both observations of quiescent neuroblasts
soon after hatching (Truman and Bate, 1988) and classical
mammalian studies (Pardee, 1989), suggest that neuroblasts
may initially be arrested in G0, and activate division by
proceeding into G1 and then into S phase. The regulated
neuroblasts are divided into sub-groups, depending on the
developmental fate of their progeny and their kinetics of
proliferation. Optic lobe neuroblasts stop cell division at
embryonic cell cycle 17 (Campos-Ortega and Hartenstein,
1985). They remain quiescent until late first instar when they
reactivate cell division and continue to divide until the pupal
stage (White and Kankel, 1978). The central brain neuroblasts
start cell division by mid-embryogenesis and become quiescent
in late embryogenesis. They reenter the cell cycle at late first
instar (Campos-Ortega and Hartenstein, 1985). Only the four
mushroom body neuroblasts and one lateral neuroblast located
at the ventrolateral side of each hemisphere begin cell division
in embryogenesis and continue to divide through larval life (Ito
and Hotta, 1991).
Several genes have been identified that affect neuroblast
proliferation (Datta and Kankel, 1992; Ebens et al., 1993;
Lipshitz and Kankel, 1985; Prokop and Technau, 1994),
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Development of a multicellular organism requires precise
coordination of cell division and cell type determination.
The selector homeoprotein Even skipped (Eve) plays a very
specific role in determining cell identity in the Drosophila
embryo, both during segmentation and in neuronal
development. However, studies of gene expression in eve
mutant embryos suggest that eve regulates the embryonic
expression of the vast majority of genes. We present here
genetic interaction and phenotypic analysis showing that
eve functions in the trol pathway to regulate the onset of
neuroblast division in the larval CNS. Surprisingly, Eve is
not detected in the regulated neuroblasts, and culture
experiments reveal that Eve is required in the body, not the
CNS. Furthermore, the effect of an eve mutation can be
rescued both in vivo and in culture by the hormone
ecdysone. These results suggest that eve is required to
produce a trans-acting factor that stimulates cell division
in the larval brain.
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including anachronism (ana), terribly reduced optic lobes
(trol) and even skipped (eve). trol was originally identified in
a genetic screen for abnormal larval brain morphology that
was due to defective patterns of neuroblast proliferation in
the larval brain (Datta and Kankel, 1992). Mutations in trol
cause a dramatic decrease in the reactivation of proliferation
from mitotic quiescence (Datta, 1995). Recent studies
suggest that trol may regulate this reactivation of neuroblast
proliferation by stimulating the G1/S transition through
upregulation of Cyclin E (CycE) expression (Caldwell and
Datta, 1998). Several studies on trol and ana have led to the
hypothesis that trol is required to overcome the repression of
neuroblast cell division imposed by ana (Datta, 1995; Datta
and Kankel, 1992; Ebens et al., 1993). eve, a homeodomain-
containing transcriptional repressor, was identified in a screen
for enhancers of the hypomorphic allele trolb22 (Park et
al., 1998). Mutations in eve enhanced both the trolb22
proliferation phenotype and the associated lethality,
indicating that eve may regulate transcription of cell cycle
genes in the trol pathway.
eve plays a key role in many cell fate decisions in the
developing embryo, ranging from segmentation to neuronal
identity. While the role of eve in the determination of specific
neuronal identity in the embryonic CNS appears to be part of
a cell-autonomous cascade of transcription factors, its function
during earlier embryonic segmentation is mediated, in part, by
regulation of the localized signaling factors Hedgehog and
Wingless (reviewed by Akam, 1987). Other studies have
suggested that eve plays a direct role in controlling
transcription of several genes, including Adh and ry (Liang and
Biggin, 1998). The contrasting views of eve as a specific
developmental regulator versus eve as a general transcriptional
factor have yet to be resolved.
Another factor implicated in the developmental coordination
of cell division is the hormone ecdysone. Ecdysone plays a role
in the initiation of imaginal histoblast division and the
proliferation of post-embryonic neuroblasts in Manduca and
Drosophila (Champlin and Truman, 1998). Ecdysone is also
required for the activation of mitotically quiescent neuroblasts
in explanted Drosophila larval CNS, but addition of ecdysone
does not rescue the proliferation phenotype of trol mutant CNS
in culture (Datta, 1999).
We present evidence that eve is required for production of
a trans-acting signal that regulates activation of neuroblast
proliferation and can be mimicked by ecdysone. We
demonstrate that loss of eve function produces increased
lethality and cell cycle arrest that is consistent with eve
function in the trol pathway, and that eve function requires an
intact C-terminal domain, in addition to the homeodomain and
a repression domain. Importantly, both Eve distribution within
the larval CNS and neuroblast division in a heterogenetic
explant/extract system show that eve expression is not required
in the regulated neuroblasts, or even in the larval CNS, to
stimulate cell division, but instead is required in some other
tissue(s). Furthermore, addition of ecdysone either in vitro or
in vivo rescues the defective neuroblast proliferation caused
by a mutation in eve. These studies reveal that heterozygous
mutations in eve in one part of the larva can affect the
generation of a signal that impacts cellular events in a separate
organ of the developing fruit fly.
MATERIALS AND METHODS
Genetic strains and transgenes
Flies were grown in standard medium at 25°C. Markers and balancer
chromosomes are described in Lindsley and Zimm (Lindsley and
Zimm, 1992). trolb22 and trolsd have been previously described
(Datta, 1995; Datta and Kankel, 1992; Shannon et al., 1972). The
trol4 and trol8 alleles were isolated from independent mutageneses
(S. D., M. C. C., M. M. R., C. R., Y. P. and S. M., unpublished).
trolb22, trol4, trol8 and trolsd mutant animals were obtained from y
trolb22 stock and from y trolx w/Binsn stocks. y trolb22; hs-CycE flies
were constructed in our laboratory from a y trolb22 and a hs-CycE
stock described previously (Caldwell and Datta, 1998). Hemizygous
y trolx w/Y; eve3/+ larvae were obtained by mating of y trolx w/Binsn
virgin female flies to eve3/CyO y+ male flies. Elliott Goldstein has
generously provided eve mutations eve58-11, eve14-10, eve20-35 and
eve10-5. The eve5/CyO, hb-lacZ stock was used to distinguish
homozygous eve5 from heterozygous embryos.
The parental eve transgene, P[eve+], capable of fully rescuing eve
null mutants, was described previously (Fujioka et al., 1999).
Derivatives of this construct (Kobayashi, et al., 2001) contain the
following alterations in the LFKPY motif near the C terminus of the
protein-coding region (see Table 3): EGN∆LFK, a STOP codon
inserted just before LFKPY, which removes the C-terminal 10 amino
acids; EGNHA, the Hairy family Groucho interaction motif WRPW
in place of FKPY; EGNPA in place of LFKPA; EGNAY in place of
LFKAY.
trol lethality screening
Virgin homozygous y trolb22 females were mated to males carrying
different eve mutations. The progeny of each population were
counted, and the ratio of y trolb22/Y; evex/+ to y trolb22/Y; CyO/+ was
calculated. The closer the ratio is to 0, the stronger the enhancement
of trolb22 lethality. Because heterozygosity at eve alone could impact
viability, males from the same genotype were also crossed to Canton
S females as a control. Virgin homozygous y trolb22; hs-CycE females
were mated to males from eve3/CyO, y+ to ask if ectopic CycE
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Fig. 1. Neuroblast division in the larval CNS. (A) Mushroom body
neuroblasts (MbNbs) divide at 0-4 hours post hatching (ph).
(B) Central brain (CNbs) and optic lobe (Onbs) neuroblasts divide by
16-20 hours ph. (C) trol is postulated to stimulate cell cycle
progression in CNbs and Onbs by increasing expression of the cell
cycle regulator Cyclin E (CycE).
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expression can rescue the enhanced lethality of hemizygous y trolb22/
Y; eve3/+ animals.
BrdU incorporation and neuroblast counting
5¢ -bromodeoxyuridine (BrdU) incorporation was analyzed as
previously described (Datta, 1995; Park et al., 1998). The average
number of BrdU-labeled neuroblasts in sibling controls was calculated
and used for normalization of neuroblast proliferation levels between
experiments. Control normalized proliferation ranged from 0.8 to 1.3
in almost all genotypes. The number of labeled neuroblasts in each
mutant population was also normalized by the average of sibling
controls to determine if mutations in specific genes result in
proliferation defects. If mutation(s) cause a proliferation phenotype,
the population distribution shifts to lower values. At least three
independent crosses were analyzed for each genotype. 
Embryo analysis and cuticle preparation
In situ hybridization was performed as described (Tautz and Pfeifle,
1989) using digoxigenin-labeled antisense engrailed probe visualized
via the alkaline phosphatase reaction with NBT/CIBP. In situ
hybridization was followed by staining with anti-Eve antiserum
(provided by M. Frasch). The antibody was visualized via the horse
radish peroxidase reaction with DAB, as described (Mullen and
DiNardo, 1995). For cuticle preparations, after devitellinization,
embryos were mounted in a 1:1 mixture of Hoyer’s reagent and 30%
lactic acid, then cleared by incubation at 55°C.
Sequence analysis, immunohistochemistry and Western
analysis of eve5 
PCR was done as previously described (Park et al., 1998). PCR
products of mutated eve5 DNA were isolated and cut with EcoRI and
SpeI. The resulting PCR fragments were cloned into the pBluescript
vector and sequenced on both strands.
Expression of Eve proteins in larval brains and embryos was
monitored by immunohistochemical analysis with mouse
monoclonal 2B8 antibody (provided by N. Patel) and guinea pig
anti-Eve polyclonal antibody (provided by D. Kosman). Secondary
antibodies were peroxidase-conjugated goat anti-mouse IgG
(Jackson ImmunoResearch, 115-035-003) or AlexaTM 488-
conjugated goat anti-mouse IgG (Molecular Probe, A-11001).
Homozygous eve5 embryos were identified by the lack of staining
with rabbit anti- b galactosidase antibody (Chemicon, AB986)
and peroxidase-conjugated goat anti-rabbit IgG (Jackson
ImmunoResearch, 111-035-003). Western analysis of Eve proteins
in embryos was done as follows: 2-4 hour old embryos were
dechorionated, protease inhibitor cocktail (Roche, 1-836-153) and
2 · Laemmli sample buffer were added to 1 · strength, and the
sample was homogenized. Whole homogenate was centrifuged for
30 seconds at 14,000 g and the supernatant analyzed. Eve was
detected either by guinea pig anti-Eve polyclonal antibody or by
mouse monoclonal 3C10 antibody (DSHB). 
Ecdysone feeding
1 mg/ml 20-hydroxyecdysone (Sigma) in BrdU-containing medium
(Caldwell and Datta, 1998; Datta, 1995; White and Kankel, 1978) was
used for ecdysone feeding and BrdU labeling from 16-20 hours
posthatching. Plain media was used from 0-16 hours post hatching.
For ecdysone feedings from 0-16 hours post hatching, 20 m l of 1
mg/ml 20-hydroxyecdysone in 10% isopropanol were mixed with 1
mg of dry yeast. Newly hatched larvae were placed in the middle of
the yeast paste to maximize probability of feeding.
Preparation of larval extract and explant culture
Larval extracts from stocks of different genotypes were prepared from
first instar larvae as previously described (Datta, 1999). Extracts were
heat-treated after preparation and stored at –70 ° C. Explant culture
analysis of different genotypes was as described (Datta, 1999).
Statistical analysis
Standard error of the mean was calculated. The significance of
differences between the mean response indices of two different
populations was evaluated using the Student’s t-test.
RESULTS
eve transheterozygotes show defective neuroblast
proliferation
We have previously shown that eve is a dominant enhancer of
trolb22, and that heterozygosity for strong eve3 or eve4
mutations does not cause defective proliferation (Park et al.,
1998), suggesting that eve is in the trol pathway. If so,
homozygous eve mutations might cause a proliferation
phenotype in the larval CNS. Complementation analysis
showed that a very small number of eve1/eve5
transheterozygous flies survived to adulthood (O’Brien et al.,
1994). This enabled us to ask if eve1/eve5 larval brains exhibit
defective proliferation. y w/Y; eve1/CyO, y+ flies were crossed
to y w; eve5/CyO, y+ females, and eve1/eve5 mutants were
selected as yellow larvae. eve1/eve5 transheterozygotes show
decreased BrdU labeling, resulting in a shift of normalized
BrdU incorporation from control values (ranging from 0.8 to
1.2 in sibling eve1/+ or eve5/+ animals, Fig. 2A,C) to lower
values (ranging from 0.4 to 0.9 in eve1/eve5 mutants, Fig.
2B,D). Comparison of average normalized proliferation reveals
a significant reduction in eve1/eve5 transheterozygotes
(0.57±0.04, n=19) versus controls (1.00±0.02, n=24).
New eve alleles define a threshold for enhancement
of trolb22 lethality
Four new eve alleles (Bour et al., 1995) were assayed for their
ability to enhance the lethality of trolb22. The phenotypic
strengths of the new alleles were assayed by examining both
their embryonic cuticular phenotypes and the expression
patterns of engrailed (en) transcripts at earlier stages (Fig. 3).
eve58-11 showed a null cuticular phenotype (Fig. 3C) and a
severely defective en expression pattern (Fig. 3D), consistent
with the lack of Eve staining, and also strongly enhanced
trolb22 lethality when heterozygous (Table 1). eve14-10 showed
a hypomorphic cuticular phenotype, clearly weaker than that
of eve58-11 (Fig. 3E), and the expression patterns of en and
Eve showed correspondingly milder defects (Fig. 3F). Both
eve10-5 and eve20-35 showed weak hypomorphic cuticular
Table 1. Dominant enhancement of trolb22 lethality by new
eve alleles
Male Female
Genotype of cross 
(male · female) evex/+ CyO/+ Ratio* evex/+ CyO/+ Ratio*
eve58-11/CyO · trolb22 0 74 0.00 28 357 0.08
eve58-11/CyO · CS 66 81 0.81 84 92 0.91
eve14-10/CyO · trolb22 283 295 0.96 977 958 1.02
eve14-10/CyO · CS 253 238 1.06 272 294 0.93
eve10-5/CyO · trolb22 118 119 0.99 347 325 1.07
eve10-5/CyO · CS 90 89 1.0 106 114 0.93
eve20-35/CyO · trolb22 67 73 0.92 310 318 0.91
eve20-35/CyO · CS 94 99 0.95 77 110 0.70
*Ratio, (number of evex/+ flies)/(number of CyO/+ flies).
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phenotypes (Fig. 3G,I), and the en and Eve patterns were
closer to wild type (Fig. 3H,J). eve10-5, eve20-35 and eve14-10
did not enhance trolb22 lethality. Taken together, the
embryonic phenotypes and the interactions with trolb22
suggest that enhancement of trolb22 lethality requires a major
reduction in eve function, close to 50% (i.e. that produced by
a null/+ eve genotype).
eve3 enhances the proliferation phenotype of two
trol alleles
We tested two trol alleles of intermediate strength, trol4 and
trol8, for their ability to be enhanced by mutations in eve. trol4
and trol8 are independent lethal alleles, and both
trol4/trolb22 and trol8/trolb22 are viable (S. D., M.
C. C., M. M. R., C. R., Y. P. and S. M.,
unpublished). Analysis of larval neuroblast
proliferation in y trol4 w/Y brains revealed a
bimodal distribution. BrdU labeling was within
control values in 43% of the samples (19 out of
44, ranging from 0.78 to 1.2), and was decreased
in 57% of the samples (25 out of 44, ranging from
0.29 to 0.76, Fig. 2E). In contrast, heterozygosity
of eve3 in a trol4 background caused defective
proliferation in 100% of the samples (total of 22
brains, Fig. 2F). Hemizygous y trol8 w/Y animals
had a much weaker proliferation phenotype than
did trol4 mutants. Only 23% (6/26) exhibited
defective proliferation, with ratios ranging from
0.28 to 0.76 (Fig. 2G). The remaining samples
(20/26) showed proliferation consistent with wild-
type levels. Introduction of a heterozygous eve3
mutation in a trol8 background increased the
number of brains with defective proliferation to
88% (21/24) (Fig. 2H). Thus, like trolb22, both
intermediate trol alleles are significantly enhanced
by eve3.
Ectopic expression of cyclin E can
rescue the enhanced neuroblast
proliferation phenotype
Ectopic expression of cyclin E from a hs-CycE
transgene consistently rescues the defective
neuroblast proliferation in trolsd first instar larval
CNSs (Caldwell and Datta, 1998). To determine
if expression of CycE would also rescue the
increased neuroblast arrest of y trolb22/Y; eve3/+
animals, we examined the effect of expression
from a hs-CycE transgene. In y trolb22/Y; eve3/+
animals, weak over expression of CycE (no heat
shock) partially rescued the neuroblast phenotype.
Without heat induction only 35% (7/20) of y
trolb22/Y; eve3/+ animals (Fig. 4E,F) carrying the
hs-CycE transgene showed defective proliferation
compared to 96% (26/27) of y trolb22/Y; eve3/+
animals without the transgene (Fig. 4C,D).
Furthermore, strong induction of CycE expression
with a 30 minute heat shock rescued the
neuroblast phenotype almost completely (96%,
22/23; Fig. 4G,H). Interestingly, weak induction
of CycE did not rescue the enhanced lethality of
y trolb22/Y; eve3/+ animals.
eve protein is not expressed in larval brain
neuroblasts
We examined the distribution of eve protein in the brains of wild-
type early, mid and late first instar larvae using
immunohistochemistry. The distribution of Eve protein within
the CNS did not change appreciably during first instar. Eve
protein is expressed in the CNS mainly in the thoracic region
(Fig. 5A,B). eve-expressing cells appear to be mostly ganglion
mother cells and neurons as characterized by their smaller size
in comparison with thoracic neuroblasts and their more internal
position on the ventral side of the thoracic ganglion. A few
ganglion mother cells and neurons in the central brain region
Y. Park and others
Fig. 2. Proliferation in eve, trol and trol;eve/+ mutants. BrdU incorporation from 16-
20 hours ph. Arrows indicate labeled neuroblasts. (A) Control brain lobe.
(B) eve1/eve5 brain lobe. Quantitation of the number of BrdU-labeled neuroblasts in
mutant and control samples. White bars indicate control samples. Black bars indicate
mutant samples. (C) Control brains. (D) eve1/eve5. (E) trol4. (F) trol4;eve3/+.
(G) trol8. (H) trol8;eve3/+.
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expressed Eve protein, but no cells in the optic lobe proliferation
center stained positively for Eve (Fig. 5A, B). Cells in the brain
lobes do stain for engrailed protein (Fig. 5C), indicating that
penetration of the tissue is not an issue. Thus, Eve does not
appear to be expressed in larval neuroblasts close to the time
when their proliferation is affected by eve and trol mutations.
In an explant proliferation assay, eve function is
required in the larval extract 
The expression pattern of eve in the larval brain suggested that
Eve protein might act in some other tissue to affect neuroblast
proliferation in the brain itself. This hypothesis was tested in
vitro using a brain explant culture system (Table 2) (Datta,
1999). When wild-type (CS) brains were cultured with wild-
type extract, 39% (7/18) of the samples had numbers of
dividing neuroblasts that were similar to those observed in
vivo. When y trolb22/Y; eve3/+ CNSs were cultured with extract
from y trolb22/Y; eve3/+ first instar larvae, just 7.8±1.3% of the
samples (4/53 total) showed in vivo levels of neuroblast
proliferation, a percentage comparable to that observed in y
trolb22/Y; eve3/+ animals in vivo. Similarly, only 6.3±1.3%
(4/66 total) of brains derived from y trolb22/Y; eve3/+ animals
showed normal neuroblast proliferation when cultured with
eve3/+ extract, consistent with a locus of action of trol within
the neuroblasts. In sharp contrast, 36% (9/25) of y trolb22/Y;
eve3/+ brains cultured with wild-type (CS) extract had levels
of neuroblast proliferation within normal in vivo levels. These
levels are close to those of wild-type brains cultured with wild-
type extract (above), suggesting that
eve is not functioning within the brain
to affect proliferation. Strikingly,
when trolb22 mutant brains (wild type
for eve) were cultured in extract
derived from eve3/+ first instar larvae
(wild type for trol), none of the
samples (0/42 total) showed normal
activation of neuroblast division,
showing that eve affects the extract.
Addition of ecdysone rescues
defective proliferation
Previously, we have shown that the
addition of ecdysone to the medium in
the brain explant culture system is
required for the activation of
neuroblast proliferation (Datta, 1999).
This led us to ask if ecdysone would
suppress the eve-mediated loss of
neuroblast proliferation. When y
trolb22/Y; eve3/+ brains were cultured
in y trolb22/Y; eve3/+ extract, to which
10 m g/ml ecdysone had been added,
40±2.7% (27/67 total, Table 2) of the
samples revealed normal activation of
neuroblast division. This is strikingly
similar to the results for wild-type
brains cultured with wild-type extract
(see above). These results were
confirmed in vivo by feeding studies.
When y trolb22/Y; eve3/+ animals
were fed 1 mg/ml ecdysone from 0-
20 hours after hatching, the number of samples showing
neuroblast proliferation within the control range rose from 4%
(1/27) (Fig. 6A,B) to 90% (27/30) (Fig. 6E,F). Interestingly,
while 68% (15/22) of y trolb22/Y; eve3/+ animals fed ecdysone
from 0-16 hours (Fig. 6C,D) showed normalized neuroblast
proliferation levels that were within the control range (0.8-1.2),
all of the samples (14/14) from animals fed ecdysone from 16-
20 hours showed normal proliferation levels, indicating that
ecdysone addition is most effective during the last four hours
of the treatment period.
Structural analysis of the eve5 allele
To investigate the structural requirements for Eve function we
analyzed the molecular lesion in the eve5 allele. It was
previously shown that the eve5 mutation removes the 3 ¢ portion
Table 2. Non-autonomous eve function is required for
neuroblast proliferation
% of Normal 
Brain 30% Larval extract proliferation*
CS CS 38.9
trolb22; eve3/+ trolb22; eve3/+ 7.8±1.3
trolb22; eve3/+ eve3/+ 6.3±1.4
trolb22 eve3/+ 0±0
trolb22; eve3/+ trolb22; eve3/+ with 10 m g/ml 20E 39.8±2.7
*% of normal proliferation, (number of samples with normal
proliferation)/(total number of samples) in independent batches of tissue
explant experiments±s.e.m.
Fig. 3. Embryonic phenotypes of eve alleles. Cuticular phenotypes. (A) Control. (C) eve58-11.
(E) eve14-10. (G) eve10-5. (I) eve20-35. engrailed expression at stage 10. (B) Control. (D) eve58-11.
(F) eve14-10. (H) eve10-5. (J) eve20-35. In all panels anterior is towards the left, ventral is downwards.
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of the Eve-coding region, leaving intact the DNA-binding
domain and a transcriptional repression domain (Park et al.,
1998). To identify the specific sequences deleted, PCR
products amplified from eve5 genomic DNA were cloned.
Sequence analysis showed (Fig. 7A) that the deletion starts at
the first base of codon ala-255 and ends at the second base of
the pro-326 codon, resulting in deletion and frameshift
mutations from amino acid 255 to amino acid 376, the C
terminus of the wild-type Eve protein. The deletion eliminates
PEST sequences found between amino acids
283 and 335, suggesting that the Eve5 protein
may have enhanced stability. This predicted
increase in stability is in agreement both with
comparative immunohistochemistry on eve5
mutant and wild-type embryos, and with
western analysis. Staining for Eve protein at
embryonic stages 6, 8 and 10 in eve5 mutant
and wild-type embryos revealed a dramatic
increase in the quantity of Eve detected in the
eve5 embryos at all three stages (Fig. 7C).
Consistent with the lack of obvious
mutations in transcriptional control regions
(Park et al., 1998), the spatial pattern of Eve
protein in the mutant embryos appears
normal, as does the level of eve mRNA (data
not shown). The putative increase in stability
of the Eve5 protein is also supported by
western analysis. Wild-type Eve is
sufficiently unstable that it cannot be
detected on western blots even in samples
prepared in the presence of high levels of
protease inhibitors from 2-4 hour embryos,
which show maximum levels of Eve
immunostaining (Fig. 7B). In contrast, the
Eve5 protein can easily be detected in
samples from heterozygous eve5/CyO
embryos by immunoblotting both with the
monoclonal antibody 3C10 and with
polyclonal anti-Eve antiserum (Fig. 7B). The
band identified by each of the anti-Eve
antibodies corresponds to approximately 40
kDa in size, while the predicted size of the
unmodified Eve5 protein is about 33 kDa,
suggesting that Eve may be post-
translationally modified in vivo. Eve protein
expressed in cultured Drosophila cells also
migrates significantly slower than expected
from its molecular weight (Han and Manley,
1993).
Transgenes with a deletion of the
Groucho-interacting domain rescue
most of eve function in the trol
pathway
The C-terminal frameshift mutation in the
eve5 allele eliminates a Groucho-interacting
motif, LFKPY, that is required for full Eve
function in segmentation (Kobayashi et al.,
2001). We showed previously that eve5
causes weak trolb22 lethality and a
corresponding enhancement of the
proliferation phenotype (Park et al., 1998). This suggests that
the Groucho-interacting domain may be required for eve
function as a cell cycle regulator. Therefore, we tested the
ability of three independent transgenes with insertions on the
second chromosome to rescue the enhancement of trol lethality
by eve3 (Table 3). The EGN∆LFK transgene, which contains a
small deletion of the Groucho-interacting motif, fully rescued
the trolb22 lethality enhanced by heterozygosity at eve; i.e. the
transgene supported viability in a trolb22; eve/+ background
Y. Park and others
Fig. 4. Rescue of neuroblast phenotypes by expression of Cyclin E. BrdU incorporation in
mutant and control brain lobes from 16-20 hours ph. (A) Control. (C) trolb22;eve3/+.
(E) trolb22;eve3/+;hs-CycE/+, no heat shock. (G) trolb22;eve3/+;hs-CycE/+, with heat
shock. Quantitation of the number of BrdU-labeled neuroblasts. (B) Control.
(D) trolb22;eve3/+. (F) trolb22;eve3/+;hs-CycE/+, no heat shock. (H) trolb22;eve3/+;hs-
CycE/+, with heat shock.
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comparable with that of CS controls. Two independent
EGNHA transgenes, containing a hairy Groucho-interacting
motif (WRPW, Fisher et al., 1996) instead of the eve Groucho-
interacting motif, showed rescue to an extent similar to that of
the EGN∆LFK transgene. Three other independent transgenes
inserted on the third chromosome, which have amino acid
substitutions that disrupt the Groucho interaction in yeast two-
hybrid assays and are similarly defective in segmentation
function (Kobayashi et al., 2001) also showed rescue of the
enhanced trolb22 lethality (Table 3). However, in the absence
of an eve mutation, none of the transgenes resulted in
enhancement of trolb22 lethality that was due to eve
overexpression to the same extent as did a wild-type eve
transgene (expressing a normal Eve protein with an intact
Groucho-interacting motif) (Park et al., 1998). These results
are consistent with the partial loss of eve segmentation function
caused by these disruptions of the Eve-Groucho interaction,
which is about 50% (Kobayashi et al., 2001), and with the fact
that a reduction of close to 50% in eve function is required to
enhance the trol phenotype. They also suggest that the Eve-
Groucho interaction contributes to Eve function in the trol
pathway (see Discussion).
DISCUSSION
eve is part of the trol pathway
Heterozygous eve mutations dramatically increase trolb22
lethality and interact synergistically with trolb22 to uncover a
proliferation phenotype (Park et al., 1998). These data suggest
that eve is a part of the trol pathway. If so, then a stronger
reduction in Eve activity alone might also cause a proliferation
phenotype. Fig. 2 clearly shows that eve1/eve5 transheterozygous
animals have a neuroblast proliferation defect, consistent with
the interpretation that eve is in the trol pathway.
A corollary of the hypothesis that eve is part of the trol
pathway is that neuroblasts arrested in a y trolb22/Y; eve3/+
animal are in the same cell cycle phase as those arrested in
trolsd mutants and can be rescued by expression of CycE, as
was previously shown for trolsd (Caldwell and Datta, 1998).
In fact, the proliferation defect in some y trolb22/Y; eve3/+
mutant brains is rescued by low levels of CycE expression,
while higher levels result in rescue in virtually every
individual (Fig. 4). The partial rescue by low levels of CycE
expression indicates that the trol pathway in y trolb22/Y; eve3/+
animals is less compromised than that in trolsd mutants, which
require high levels to obtain rescue, and further supports the
hypothesis that trol and eve function in a common
proliferation pathway.
The eve-trol interaction is not allele specific
Known mutations in both the eve homeodomain (eve1 and eve2)
and a transcriptional repression domain (eve4) enhance trolb22
phenotypes, suggesting that trolb22 enhancement is due to eve
function as a DNA-binding transcriptional repressor. However,
eve mutations do not enhance the strongest trol allele, trolsd.
This led us to ask whether trolb22 enhancement by eve was due
to a partial loss of function of eve and trol or to allele-specific
interactions. We tested several new eve alleles (Table 1), and
found a good correspondence between the ability to enhance
trol and the severity of the eve embryonic phenotype, strongly
Fig. 5. Eve localization in the larval brain. Eve localization in late
first instar brain. (A) Ventral view. (B) Dorsal view. (C) Engrailed
localization in a late first instar brain. In panels A and B anterior is
towards the left. In panel C anterior is to the top.




(male · female) eve3, P/+ CyO/+ Ratio*
EGND LFK (A-2) · trolb22 240 119 2.1– 0.3 (n=3)
EGND LFK (A-2) · CS 343 282 1.2±0.06 (n=2)
EGNHA (C-2) · trolb22 404 176 2.7±0.61 (n=3)
EGNHA (C-2) · CS 539 407 1.4±0.14 (n=2)
EGNHA (F-3) · trolb22 223 139 1.7±0.23 (n=3)
EGNHA (F-3) · CS 462 392 1.2±0.04 (n=2)
eve3/+; P/+ CyO/+; P/+ Ratio‡
P[eve+] · trolb22 253 31 0.12±0.02 (n=3)
P[eve+] · CS 85 83 0.98
EGNPA (F-2) · trolb22 312 180 0.53±0.08 (n=3)
EGNPA (F-2) · CS 513 417 0.82±0.04 (n=2)
EGNAY (D-1) · trolb22 270 98 0.30±0.07(n=4)
EGNAY (D-1) · CS 293 249 0.84±0.08 (n=2)
EGNAY (E-1) · trolb22 279 91 0.31±0.03 (n=3)
EGNAY (E-1) · CS 354 368 1.1±0.1 (n=2)
*Ratio, (number of eve3, P/+ flies)/(number of CyO/+ flies).
‡Ratio, (number of CyO/+; P/+ flies)/(number of eve3/+; P/+flies). 
Contents inside parentheses of each genotype refer to independent
transgenic lines.
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supporting the hypothesis that the trolb22-eve interaction is due
to a general loss of eve function. The lack of trol enhancement
by weak eve mutations also indicates that enhancement
requires a reduction in Eve activity of close to 50%. However,
trol enhancement is not due to a defect in segmentation. In
addition to the fact that heterozygous eve mutants produce few
segmentation defects, this is supported indirectly by
observations on another transcriptional regulator, ftz, which
was also identified as a trol enhancer (C. D. Hough and S. D.,
unpublished). Heterozygous ftz mutations enhance trolb22
lethality and produce a proliferation phenotype similar to that
of eve mutations. A ftz transgene that restores the early pair
rule expression of ftz (but not CNS expression) cannot rescue
enhancement (Y. P. and S. D., unpublished), implying that
segmentation defects are not the cause of trol enhancement by
ftz.
Having established that the eve-trol interaction is not eve
allele specific, we proceeded to ask whether other trol
mutations could also be enhanced by eve.
Two independent trol alleles of intermediate
strength also showed eve enhancement (Fig.
2), clearly indicating that the eve-trol
interaction is not due to specific
characteristics of the trolb22 allele or to
background mutations in the trolb22 stock.
We compared the average reduction of
normalized proliferation in different mutant
populations. For the trol4 and trol8 mutations,
only the population with a mutant phenotype
were included in the calculation. Strong trolsd
samples led to a reduction in normalized
proliferation of 0.66±0.04 (n=13, Y. P. and S.
D., unpublished data) of control levels,
consistent with published results (Datta,
1995). eve1/eve5 transheterozygotes showed a
reduction to 0.57±0.04 (n=19), while trol4/Y;
eve3/+ and trol8/Y; eve3/+ brains showed a
reduction to 0.57±0.03 (n=22) and 0.57±0.03
(n=21), respectively. Thus, while not all
animals of each genotype had a proliferation
phenotype, the magnitude of the proliferation
phenotype, when present, was statistically
identical in all the mutant genotypes
examined. This consistent reduction of
proliferation in different mutant animals
suggests that a specific subpopulation of
neuroblasts may require the activity of trol
and eve in order to activate cell division, while
the remaining neuroblasts use an alternative
mechanism, which either is independent of or
somehow compensates for a loss of activity in
the trol pathway.
Eve protein requires several domains
to control neuroblast proliferation
We had shown previously that the DNA-
binding domain and a transcription repression
domain in the Eve protein are likely to be
required for neuroblast cell cycle activation
(Park et al., 1998). Sequence analysis of the
eve5 mutation suggested that the deletion of
PEST sequences within the Eve5 protein (Sackerson, 1995) and
the resulting protein stability, as demonstrated by both western
and immunohistochemical analysis (Fig. 7B,C), might
contribute to eve5 enhancement of trolb22. This possibility is
consistent with our previous observation that overexpression of
eve by addition of eve transgenes also enhances trolb22 lethality
(Park et al., 1998). Alternatively, deletion of a domain at the C
terminus of the Eve5 protein, which was recently shown to
interact functionally with the corepressor Groucho (Kobayashi
et al., 2001), could have diminished its activity as a cell cycle
regulator. This interpretation is consistent with the partial-loss-
of-function embryonic phenotype of eve5. The role of
sequences at the C terminus of Eve was investigated using eve
transgenes with mutant or substituted Groucho-interaction
motifs.
Transgenes with truncation and amino acid substitutions in
the C-terminal Groucho-interacting motif rescue lethality
caused by the loss of Eve activity caused by eve3. However,
Y. Park and others
Fig. 6. Rescue of neuroblast proliferation defects by ecdysone. BrdU incorporation in
brain lobes of mutant and control brains from 16-20 hours ph. (A) trolb22;eve3/+.
(C) trolb22;eve3/+ fed ecdysone from 0-16 hours ph. (E) trolb22;eve3/+ fed ecdysone from
0-20 hours ph. Quantitation of the number of BrdU labeled neuroblasts.
(B) trolb22;eve3/+. (D) trolb22;eve3/+ fed ecdysone from 0-16 hours ph. (F) trolb22;eve3/+
fed ecdysone from 0-20 hours ph.
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these same transgenes, in the presence of two wild-type eve
alleles, are not sufficient to enhance trolb22 lethality, while
transgenes that express the normal Eve protein do cause
enhancement. This suggests that the activity of each of the
Groucho-motif mutant eve transgenes is lower than that of
wild-type eve+ and is consistent with the fact that the
transgenes have a reduced function in segmentation
(Kobayashi et al., 2001). These data indicate that the Groucho-
interaction domain, in addition to the DNA-binding domain
and the Groucho-independent transcriptional repression
domain, is necessary for the full function of the Eve protein in
promoting neuroblast proliferation.
eve acts non-autonomously to control proliferation
All of the genetic evidence to date suggests that eve functions
as a transcriptional regulator in the trol pathway. The most
straightforward explanation is that eve acts within the regulated
neuroblasts to promote CycE expression. Surprisingly, while
Eve protein is found in the larval CNS (Fig. 5) in a pattern
similar to that observed in other insect systems (Duman-Scheel
and Patel, 1999), It cannot be detected in the regulated
neuroblasts at any time from larval hatching to the point at
which the cells have already entered S phase. This unexpected
result led to the hypothesis that eve might function outside of
the larval brain to provide a trans-acting signal required for
neuroblast proliferation.
We have previously demonstrated that a CNS mutant for
trolsd shows a defect in neuroblast proliferation even
when cultured with wild-type whole-body extract,
suggesting that trol is required only within the larval CNS
for normal activation of neuroblast division (Datta, 1999).
We used the same system to determine whether eve was
required in the CNS or the body for normal proliferation
to occur. As shown in Table 2, when trolb22 brains are
cultured with extract derived from eve3/+ animals, a
proliferation defect is observed. The magnitude of the
defect is similar to that of trolb22/Y; eve3/+ brains cultured
with trolb22/Y; eve3/+ extract, and comparable with the
defect in trolb22/Y; eve3/+ animals in vivo. Thus, a
decrease in eve activity within the body can precipitate a
lack of neuroblast proliferation within a sensitized trol
larval brain.
Eve-mediated enhancement of defective
neuroblast proliferation can be rescued by
ecdysone
Analysis of explants had previously shown that ecdysone
enabled activation of neuroblast division and could
substitute for larval extract (Datta, 1999). Furthermore,
addition of ecdysone did not rescue the proliferation
phenotype of cultured trolsd mutant brains, implying that
ecdysone acts upstream of trol. Addition of ecdysone to
extract from trolb22/Y; eve3/+ animals produced normal
proliferation in cultured trolb22/Y; eve3/+ mutant brains
(Table 2). Thus, ecdysone can overcome the lack of eve-
induced activity in the extract. The ability of ecdysone to
compensate for low eve expression was also seen in vivo
in the rescue of proliferation defects of trolb22/Y; eve3/+
animals by ecdysone feeding (Fig. 6). Interestingly, almost
complete rescue was obtained when animals were fed
ecdysone from 16-20 hours posthatching, indicating that
the time between ecdysone action and S phase entry is at most
four hours.
eve, ecdysone and activation of imaginal neuroblast
division
Mutations in eve produce specific defects in embryonic
segmentation and the determination of neuronal identities in
the embryonic CNS. Analyses of these phenotypes has led to
the elucidation, especially for segmentation, of a complex
molecular circuit that controls the expression of specific
genes to set the body plan of the embryo. Yet some studies
have also suggested that mutations in eve result in changes in
the spatial pattern of expression of 87% of the genes in the
embryo, even those such as ry, whose linkage to changes in
segment identity are not obvious (Liang and Biggin, 1998).
So how does a gene like eve with such apparent specificity in
mutant phenotype and expression pattern affect the
expression of a majority of genes in such a global fashion?
Biochemical analyses indicate that Eve binds throughout the
length of many genes, although how that binding might
regulate gene expression is not clear (Walter et al., 1994).
Another possibility is that eve is also required for the
formation of an organismal-level trans-acting signal that
affects the expression of other genes.
The genetic interaction between eve and trol has all the
characteristics expected for two components of a common
pathway: (1) the eve-trol interaction is not allele specific and
Fig. 7. Molecular analysis of eve5. (A) Nucleotide and predicted protein
sequence comparison of eve5 with wild type. Shaded boxes indicate
predicted PEST sequences. Underline indicates Groucho interacting motif.
(B) Western blot of eve5/+ and control samples. Lanes 1, 2 eve5/CyO; 2, 5
eve4/CyO; 3, 6 CS. (C) Immunohistochemical detection of wild-type Eve at
late stage 6 of embryogenesis (left), when wild-type Eve protein levels are
decreasing and Eve5 protein at early stage 7 (panel).
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the known functional domains of Eve are implicated in the
interaction; (2) the strength of the interaction mirrors the
strength of the eve allele in segmentation; (3) eve mutants
themselves have the predicted proliferation phenotype; and (4)
neuroblasts arrested in trolb22;eve/+ can be rescued by
expression of CycE, as can the neuroblasts arrested in a strong
trol mutant. The latter is especially revealing, as induction of
CycE expression in trol mutants results in the activation of cell
division ONLY in the number of neuroblasts appropriate to
the developmental stage of the induction (Caldwell and Datta,
1998). That is, not all mitotically quiescent neuroblasts are
arrested at the same cell cycle phase, and the extent to which
CycE is a limiting factor is developmentally controlled.
Therefore, as in embryonic segmentation and determination of
neuronal identity, eve appears to function in a specific genetic
pathway to affect the behavior of specific cells at specific
times.
However, Eve is not detectable in regulated neuroblasts at
any time during first instar. Furthermore, eve function is not
required within the larval CNS, but is required within the larval
body from which extracts are prepared. Moreover, low levels
(10-20%) of extract made from eve+ (CS) animals will not
support activation of neuroblast division while higher
concentrations will (Y. P. and S. D., data not shown). This
concentration dependence indicates that eve does not inhibit
production of a trans-acting proliferation repressor that is
produced at higher levels in a eve mutant, as dilution of such
a repressor would allow neuroblast division at lower rather than
higher extract concentrations. These results strongly suggest
that eve function is required for the production of a trans-acting
factor that stimulates neuroblast division.
Is ecdysone the trans-acting factor produced in response to
eve? Ecdysone can rescue eve-dependent proliferation defects
both in vivo and in vitro (Fig. 6, Table 2), but not the
proliferation defect of trol mutants in vitro (Datta, 1999).
This suggests that ecdysone acts upstream of trol, as would
be expected if it is the eve-dependent trans-acting signal, and
trol acts within the receiving cells. However, while the
ecdysone receptor has been detected in a few neurosecretory
cells of the first instar CNS, it has not been detected in
neuroblasts (Truman et al., 1994). This may indicate that only
a few high-affinity receptors are required to transduce the
ecdysone signal, or that ecdysone acts indirectly through the
products of the neurosecretory cells. However, as Eve is not
detectable in the neurosecretory cells in wild-type brain lobes
(Fig. 5), it is unlikely that the added ecdysone rescues mutant
animals by compensating for a loss of Eve activity in those
cells. In each of these cases, eve could be acting through
ecdysone production. Alternatively, ecdysone may act
through a parallel pathway to that stimulated by an
(unknown) eve-dependent signal. While the relationship
between eve and ecdysone is not yet clear, it seems likely that
eve is required for the production of an organismal-level
trans-acting signal that is specifically required to stimulate
larval neuroblast proliferation.
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